Completed NA INTERVENTIONAL 1-arm NCT04720040

The Efficacy and Safety of tDCS in Patients With Mild to Moderate Major Depressive Disorder

Using YMS-201B in Patients With Mild to Moderate Major Depressive Disorder To Evaluate Efficacy and Safety for the Effect of Improving Depressive Symptoms Open, Single-group, Multicenter Confirmatory Clinical Trial

Sponsor: Hallym University Medical Center

Conditions Depression

Interventions Mind STIM

Updated 4 times since 2021 Last updated: Jan 18, 2021 Started: Dec 23, 2019 Primary completion: Aug 31, 2020 Completion: Oct 15, 2020

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT04720040, this NA trial focuses on Depression and remains completed. Sponsored by Hallym University Medical Center, it has been updated 4 times since 2019, reflecting limited change activity. Mental health research at this phase helps define safety and dosing parameters for future study.

Status Flow

Change History

4 versions recorded

Sep 2025 — Present [monthly]

Completed NA
Sep 2024 — Sep 2025 [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Feb 2021 — Jul 2024 [monthly]

Completed NA

First recorded

Dec 2019

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Hallym University Medical Center
Inje University
Korea University
Seoul National University Bundang Hospital
Soonchunhyang University Hospital
The Catholic University of Korea
Ybrain Inc.

Data source: Ybrain Inc.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Seongnam-si, South Korea